<?xml version="1.0" encoding="UTF-8"?>
<ref id="B23">
 <label>23</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Nabavi</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Daglia</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Dâ€™Antona</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Sobarzo-Sanchez</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Talas</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Nabavi</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Natural compounds used as therapies targeting to amyotrophic lateral sclerosis</article-title>
  <source>
   <italic toggle="yes">Current Pharmaceutical Biotechnology</italic>
  </source>
  <year>2015</year>
  <volume>16</volume>
  <issue>3</issue>
  <fpage>211</fpage>
  <lpage>218</lpage>
  <pub-id pub-id-type="doi">10.2174/1389201016666150118132224</pub-id>
  <pub-id pub-id-type="other">2-s2.0-84944890821</pub-id>
  <?supplied-pmid 25601606?>
  <pub-id pub-id-type="pmid">25601606</pub-id>
 </element-citation>
</ref>
